<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000864/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><disease>Spinal Cord Injury</disease><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000864</full_dataset_link><study_factor>timept:P21 | Grouping:CTRL</study_factor><study_factor>timept:P21 | Grouping:PAR1</study_factor><study_factor>timept:P21 | Grouping:PAR2</study_factor><study_factor>timept:P60 | Grouping:CTRL</study_factor><study_factor>timept:P60 | Grouping:PAR1</study_factor><study_factor>timept:P60 | Grouping:PAR2</study_factor><tissue>Spinal Cord</tissue><sample_protocol>Reversed phase POSITIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><data_protocol></data_protocol><omics_type>Metabolomics</omics_type><species>Mus Musculus</species><submitter_affiliation>Mayo Clinic</submitter_affiliation><metabolite_name>C18:1-cer</metabolite_name><metabolite_name>SPA</metabolite_name><metabolite_name>C16-cer</metabolite_name><metabolite_name>C8-cer</metabolite_name><metabolite_name>C18-cer</metabolite_name><metabolite_name>Sph</metabolite_name><metabolite_name>C20-cer</metabolite_name><metabolite_name>C22-cer</metabolite_name><metabolite_name>C18-dh cer</metabolite_name><metabolite_name>C24-cer</metabolite_name><metabolite_name>C16-dh cer</metabolite_name><metabolite_name>S1P</metabolite_name><metabolite_name>C18:1-dh cer</metabolite_name><metabolite_name>C24:1-cer</metabolite_name><metabolite_name>C14-cer</metabolite_name><name_synonyms>pbp2, 3.4.22.-, F7D19.13, Laboratory, ceramides, f2r-a, Mus domesticus, mini-ICE, CASP-14, Ceramide, DmelCG8201, ONR1, CF2R, House Mouse, F7D19_13, House, dPAR-1, D15Ertd747e, Cer, Mus musculus domesticus, PARq, dPar-1, GPCR42, Mice, 27C1, Gpr172b, PXR, Swiss, l(2)k06323, Swiss Mice, mRFT1, Cf2r, par-1, PAR-2, HELIX-LOOP-HELIX 1, PAR-1, emk-1, GPR11, emk-2, Par-1, Par-2, Myelin Sheaths, CG16701, PHY RAPIDLY REGULATED 1, TR, PAR, par1, CG8201, SXR, Sheath, PRR, CASP14, mouse, dPAR1, dPar1, ThrR, dMARK, AI482343, CG11960, ctak1, CG30131, CG30132, EMK, Mus, N-acylated sphingoid, anon-WO0210402.19, DPAR-1, Mini-ICE, SNQ3, Mus musculus., BXR, Mus musculus, SAR, HTR, Caspase-14 subunit p10, HLH1, mice, a ceramide, Swiss Mouse, Sheaths, House Mice, Caspase-14 subunit p19, Gpcr11, MICE, c-tak1, Laboratory Mice, domesticus, emk1, Myelin, l(2)27C1, BcDNA:RH48823, par1b, 2010003P03Rik, MARK, DPar1, Par-1A, PAR2, Par2, Mouse, PAR1, Par1, Laboratory Mouse</name_synonyms><sample_synonyms>backward, reversed.</sample_synonyms></additional><is_claimable>false</is_claimable><name>Targeting Myelin Ceramides in PAR1 and PAR2 Mice after SCI</name><description/><dates><publication></publication></dates><accession>ST000864</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>